1-20 of 41
Luc Xerri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Follicular lymphoma comprises germinal center–like and memory-like molecular subtypes with prognostic significance

Clinical Trials & Observations
Camille Laurent, Preeti Trisal, Bruno Tesson, Sahil Seth, Alicia Beyou, Sandrine Roulland, Bastien Lesne, Nathalie Van Acker, Juan-Pablo Cerapio, Loïc Chartier, Arnaud Guille, Matthew E. Stokes, C. Chris Huang, Sarah Huet, Anita K. Gandhi, Franck Morschhauser, Luc Xerri
Journal: Blood
Blood (2024) 144 (24): 2503–2516.
https://doi.org/10.1182/blood.2024024496
Published: 2024
Includes: Supplemental data
Journal Articles

Combining PET/CT and Ctdna Assessments at 6 Months from Induction Treatment Better Predicts Outcome in Previously Untreated Patients with Follicular Lymphoma: A Relevance Ancillary Lysa Study

Alexis Claudel, Anne Ségolène Cottereau, Emmanuel Bachy, Pierre Feugier, Rene-Olivier Casasnovas, Corinne Haioun, Herve Tilly, Nicolas Daguindau, Guillaume Cartron, Emmanuelle Nicolas Virelizier, Pauline Brice, Benoit Tessoulin, Christophe Fruchart, Sylvie Glaisner, Alain Jacques Delmer, Emmanuel Fleck, Gian Matteo Pica, Hacene Zerazhi, Stephanie Guidez, Morgane Cheminant, Luc Xerri, Laetitia Vercellino, Loïc Chartier, Lucie Gomes, Pierre-Julien Viailly, Marie-Helene Delfau, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 170.
https://doi.org/10.1182/blood-2023-178030
Published: 2023
Journal Articles

Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy

David Sibon, Jean Marc Schiano De Colella, Emmanuel Itti, Thu-Ha Dao, Lucie Oberic, Romain Ricci, Camille Laurent, Luc Xerri, Marc André, Emmanuelle Nicolas Virelizier, Christophe Bonnet, Alexandre Karangwa, Luc-Matthieu Fornecker, Emmanuel Bachy, Marie Bannier, Alexandra Traverse-Glehen, Youlia Kirova, Cyrielle de Lacheisserie, Romain Ould-Ammar, Patrick Fogarty, Nadia Amara, Virginie Fataccioli, Hervé Tilly, Lionel Tortolano, Romain Bosc, Fabien Le Bras, Philippe Gaulard, Corinne Haioun
Journal: Blood
Blood (2023) 142 (Supplement 1): 4439.
https://doi.org/10.1182/blood-2023-188896
Published: 2023
Journal Articles

Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey

Charlotte Syrykh, Charlotte Chaouat, Elsa Poullot, Nadia Amara, Virginie Fataccioli, Marie Parrens, Alexandra Traverse-Glehen, Thierry-Jo Molina, Luc Xerri, Laurent Martin, Romain Dubois, Vanessa Lacheretz-Szablewski, Marie-Christine Copin, Anne Moreau, Marie-Pierre Chenard, Bastien Cabarrou, Amélie Lusque, Philippe Gaulard, Pierre Brousset, Camille Laurent
Journal: Blood
Blood (2022) 140 (24): 2573–2583.
https://doi.org/10.1182/blood.2022015520
Published: 2022
Includes: Supplemental data
Journal Articles

A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study

Herve Ghesquieres, Youenn Drouet, Susan L. Slager, Franck Morschhauser, Sara Galimberti, Dennis P. Robinson, Emilie Thomas, Anne J. Novak, Luc Xerri, Stefano Luminari, Aurelie Verney, Camille Laurent, Lisa M. Rimsza, Thomas M. Habermann, Massimo Federico, Brian K. Link, Gilles Salles, James R. Cerhan
Journal: Blood
Blood (2022) 140 (Supplement 1): 1307–1309.
https://doi.org/10.1182/blood-2022-167466
Published: 2022
Journal Articles

Sub-Cutaneous Administration of Rituximab Triggers a Pro-Phagocytic Phenotype of Monocytic Compartment in Low-Tumor Burden Follicular Lymphoma Patients Included in the Flirt Clinical Trial, a Lysa Study

Mikael Roussel, Cedric Menard, Delphine Rossille, Julien Saint-Vanne, Joelle Dulong, Emmanuel Bachy, Herve Tilly, Delphine Pranger, Franck Morschhauser, Luc Xerri, Guillaume Cartron, Karin Tarte
Journal: Blood
Blood (2022) 140 (Supplement 1): 6462–6463.
https://doi.org/10.1182/blood-2022-169295
Published: 2022
Journal Articles

Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R 2 ) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance

Franck Morschhauser, Loretta Nastoupil, Pierre Feugier, Jean Marc Schiano De Colella, Hervé Tilly, M. Lia Palomba, Emmanuel Bachy, Christophe Fruchart, Edward Libby, Rene-Olivier Casasnovas, Ian W. Flinn, Corinne Haioun, Herve Maisonneuve, Loic Ysebaert, Nancy L. Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Steven Le Gouill, Nicolas Daguindau, Vincent Delwail, Gian-Matteo Pica, Alejandro Martin Garcia-Sancho, Armando Lopez-Guillermo, Jean-Francois Larouche, Kiyoshi Ando, Gomes da Silva Maria, Marc André, Ka Lung Wu, Laurie H. Sehn, Koji Izutsu, Guillaume Cartron, Argyrios Gkasiamis, Russell Crowe, Luc Xerri, Nathan H. Fowler, Gilles Salles
Journal: Blood
Blood (2021) 138 (Supplement 1): 2417.
https://doi.org/10.1182/blood-2021-148218
Published: 2021
Journal Articles

Breast Implant Associated-Anaplastic Large-Cell Lymphoma (BIA-ALCL): Data Based on the Lymphoma Study Association (LYSA) Registry. Promising Results of Brentuximab Vedotin Combined with Cyclophosphamide, Doxorubicin and Prednisone (BV-CHP) As First Line Treatment for Patient Requiring Chemotherapy

Fabien Le Bras, Jean Marc Schiano De Colella, Lucie Oberic, Emmanuel Itti, Thua-Ha Dao, Camille Laurent, Luc Xerri, Emmanuel Bachy, Alexandra Traverse-Glehen, Christophe Bonnet, Marc André, Luc Mathieu Fornecker, Marie Bannier, Bohrane Slama, Youlia Kirova, Emmanuelle Nicolas-Virelizier, Manon Croix, Patrick Fogarty, Nadia Amara, Virginie Fataccioli, Romain Ricci, Hervé Tilly, Lionel Tortolano, Romain Bosc, Philippe Gaulard, Corinne Haioun
Journal: Blood
Blood (2021) 138 (Supplement 1): 1387.
https://doi.org/10.1182/blood-2021-150478
Published: 2021
Journal Articles

EBV + diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant–related lymphomas

Clinical Trials & Observations
Lénaïg Mescam, Vincent Camus, Jean-Marc Schiano, José Adélaïde, Jean-Michel Picquenot, Arnaud Guille, Marie Bannier, Philippe Ruminy, Pierre-Julien Viailly, Fabrice Jardin, Reda Bouabdallah, Isabelle Brenot-Rossi, Elodie Bohers, Cyrielle Robe, Camille Laurent, Daniel Birnbaum, Andrew Wotherspoon, Philippe Gaulard, Luc Xerri
Journal: Blood
Blood (2020) 135 (22): 2004–2009.
https://doi.org/10.1182/blood.2019003408
Published: 2020
Includes: Supplemental data
Journal Articles

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

Camille Laurent, Alina Nicolae, Cécile Laurent, Fabien Le Bras, Corinne Haioun, Virginie Fataccioli, Nadia Amara, José Adélaïde, Arnaud Guille, Jean-Marc Schiano, Bruno Tesson, Alexandra Traverse-Glehen, Marie-Pierre Chenard, Lénaïg Mescam, Anne Moreau, Catherine Chassagne-Clement, Joan Somja, Frédéric Escudié, Marc André, Nadine Martin, Laetitia Lacroix, François Lemonnier, Anne-Sophie Hamy, Fabien Reyal, Marie Bannier, Lucie Oberic, Nais Prade, François-Xavier Frénois, Asma Beldi-Ferchiou, Marie-Helene Delfau-Larue, Reda Bouabdallah, Daniel Birnbaum, Pierre Brousset, Luc Xerri, Philippe Gaulard
Journal: Blood
Blood (2020) 135 (5): 360–370.
https://doi.org/10.1182/blood.2019001904
Published: 2020
Includes: Supplemental data
Journal Articles

Validation of the PRIMA-Prognostic Index for Patients Treated with Rituximab Plus Chemotherapy and Refinement of Prognostic Parameters for Patients on Rituximab Plus Lenalidomide in the Phase III Relevance Trial

Edith Julia, Nathan H Fowler, MD, Emmanuel Bachy, MD PhD, Pierre Feugier, MD PhD, Reda Bouabdallah, Herve Tilly, MD PhD, M. Lia Palomba, MD, Christophe Fruchart, MD, Edward N. Libby, III, MD, Rene-Olivier Casasnovas, MD, Ian W. Flinn, MD PhD, Corinne Haioun, MD PhD, Herve Maisonneuve, MD, Loic Ysebaert, MD PhD, Nancy L. Bartlett, MD, Kamal Bouabdallah, MD, Pauline Brice, Vincent Ribrag, MD, Nicolas Daguindau, MD, Steven Le Gouill, Gian-Matteo Pica, MD, Alejandro Martín, MD PhD, Armando Lopez-Guillermo, Jean-Francois Larouche, MD, Kiyoshi Ando, Gomes da Silva Maria, MD PhD, Marc André, Ka Lung Wu, MD, Laurie H Sehn, MD, Kensei Tobinai, MD PhD, Guillaume Cartron, Richard Delarue, Myron Czuczman, Luc Xerri, MD PhD, Gilles A. Salles, MD PhD, Franck Morschhauser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1524.
https://doi.org/10.1182/blood-2019-129024
Published: 2019
Journal Articles

Somatic Mutation Profile Analyzed By Next-Generation Sequencing in Relapsed/Refractory Follicular Lymphoma Treated with Idelalisib

Philippine Robert, Cédric Rossi, MD PhD, Romain Aucagne, PhD, Caroline Chapusot, Selim Ramla, MD, Robin Noel, MD, Reda Bouabdallah, Morgan Avenin, MD, Luc Xerri, MD PhD, Elise Toussaint, MD, Marie-Pierre Chenard, MD PhD, Luc Mathieu Fornecker, MD PhD, Adrien Chauchet, MD, Isabelle Bedgedjian, MD, Anne Quinquenel, MD, Saviz Nasri, Aude Marchal, MD PhD, Alain Jacques Delmer, MD PhD, Juliette Bouteloup, MD, Jean-Noel Bastie, MD PhD, Laurent Martin, MD PhD, Mary Callanan, PhD, Olivier Casasnovas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1503.
https://doi.org/10.1182/blood-2019-126459
Published: 2019
Journal Articles

Implication of Inherited Genetic Variants Associated with Follicular Lymphoma Susceptibility in the Prognosis of Patients Treated By Immunochemotherapy in PRIMA Study

Herve Ghesquieres, MD PhD, Youenn Drouet, PhD, Sarah Huet, PharmD PhD, Guillaume Cartron, Marie-Helene Delfau, MD PhD, Fritz Offner, MD, Pauline Brice, Luc Xerri, MD PhD, Reda Bouabdallah, Gilles A. Salles, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2780.
https://doi.org/10.1182/blood-2019-130357
Published: 2019
Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Fabien Le Bras, Philippe Gaulard, MD PhD, Marc Andre, MD, Corinne Haioun, MD PhD, Romain Bosc, MD PhD, Camille Laurent, MD PhD, Lionel Tortelano, PD, Thua-Ha Dao, MD, Emmanuel Itti, MD PhD, Caroline Malhaire, MD, Schiano de Colella Jean Marc, MD, Marie Bannier, MD, Emmanuel Bachy, MD PhD, Borhane Slama, MD, Luc Mathieu Fornecker, MD PhD, Lucie Oberic, MD, Alexandra Traverse-Glehen, MD PhD, Manon Croix, Julie Bonnefoy, Patrick Fogarty, Feriel Bouabbas, Nadia Amara, Virginie Fataccioli, PhD, Romain Ricci, Tania Cassubie-Mercier, Youlia Kirova, MD, Fabien Reyal, Herve Tilly, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Luc Xerri, MD PhD, Christophe Bonnet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4021.
https://doi.org/10.1182/blood-2019-129123
Published: 2019
Journal Articles

Follicular Lymphoma Grade 3A Exhibits Pathological and Cytogenetic Diversity, but Similar Prognosis Compared to FL Grade 1-2: Pooled Analysis of 1757 Follicular Lymphomas from the PRIMA and Relevance Trials

Camille Laurent, MD PhD, Danielle Canioni, MD, Bettina Fabiani, MD, Véronique Meignin, Catherine Chassagne-Clément, MD, Peggy Dartigues-Cuillères, MD, Christiane Copie, MDPhD, Guillaume Cartron, Franck Morschhauser, MD, Gilles Salles, MD PhD, Luc Xerri, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 778.
https://doi.org/10.1182/blood-2018-99-115831
Published: 2018
Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The French Lymphoma Study Association (LYSA) Registry Data

Fabien Le Bras, Camille Laurent, MD PhD, Romain Bosc, MDPhD, Lionel Tortelano, PD, Tu Ha Dao, MD, Emmanuel Itti, MD PhD, Caroline Malhaire, MD, Jean Marc Schiano de Collela, MD, Marie Bannier, MD, Emmanuel Bachy, MD PhD, Bohrane Slama, MD, Luc Matthieu Fornecker, Lucie Oberic, MD, Alexandra Traverse-Glehen, MD PhD, Youlia Kirova, MD, Reyal Fabien, MD, Herve Tilly, MD, Emmanuelle Nicolas-Virelizier, MD, Luc Xerri, MD PhD, Philippe Gaulard, MD, Corinne Haioun, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1641.
https://doi.org/10.1182/blood-2018-99-111659
Published: 2018
Journal Articles

Long Term Follow-up of the PRIMA Study: Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years

Gilles Andre Salles, MD PhD, John Francis Seymour, MBBS, Pierre Feugier, MD, Fritz Offner, MDhD, Armando Lopez-Guillermo, David Belada, MD PhD, Luc Xerri, MD PhD, Reda Bouabdallah, MD, John Catalano, Pauline Brice, MD, Corinne Haioun, Alejandro Martín, MD PhD, Lars Moller Pedersen, Alain Jacques Delmer, MD, David Simpson, MBChB, Sirpa Leppa, MD, Pierre Soubeyran, MD PhD, Rene-Olivier Casasnovas, MD, Tanin Intragumtornchai, MD, Vincent Ribrag, Maria Gomes Silva, Emmanuelle Nicolas-Virelizier, MD, Thomas Lister, MD, Jane Estell, Gustavo Milone, MD, Anne Sonet, MD, Julie Assemat, Harald Zeuner, Bertrand Coiffier, MD PhD, Herve Tilly
Journal: Blood
Blood (2017) 130 (Supplement 1): 486.
https://doi.org/10.1182/blood.V130.Suppl_1.486.486
Published: 2017
Journal Articles

Prognostic Value of P53 and Myc Protein Expression in Follicular Lymphomas in the PRIMA Trial in the Lysa Group

Danielle Canioni, MD, Laure Joseph, MD, Bettina Fabiani, MD, Catherine Chassagne-Clément, MD, Peggy Dartigues-Cuillères, MD, Frederic Charlotte, MD, Pauline Brice, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Anne Sonet, MD, Gilles Salles, MD PhD, Luc Xerri, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1508.
https://doi.org/10.1182/blood.V130.Suppl_1.1508.1508
Published: 2017
Journal Articles

A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma

Franck Morschhauser, MD PhD, Guillaume Cartron, MD PhD, Gilles A. Salles, Fontanet Bijou, MD, Christophe Fruchart, MD, Krimo Bouabdallah, MD, Pierre Feugier, MD PhD, Steven Le Gouill, MD PhD, Hervé Tilly, MD PhD, Cecile moluçon-Chabrot, MD, Marie Maerevoet, MD, Rene-Olivier Casasnovas, MD, Eric W Van Den Neste, MD PhD, Pierre Zachee, Koen Van Eygen, MD, Achiel Van Hoof, MD, Christophe Bonnet, MD PhD, Corinne Haioun, MD, Marc Andre, MD, Luc Xerri, MD PhD, Roch Houot, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4202.
https://doi.org/10.1182/blood.V128.22.4202.4202
Published: 2016
Journal Articles

Mutation Load and a Functional T Effector Signature May Distinguish Immunologically Distinct and Clinically Relevant Lymphoma Subsets

Chris Bolen, PhD, Ronald McCord, PhD, Garrett Frampton, PhD, Richard Bourgon, PhD, Elizabeth A. Punnoose, PhD, Edith Szafer-Glusman, PhD, Pierre Sujobert, MD PhD, Luc Xerri, MD PhD, Sarah Huet, PharmD, PhD, Gilles Salles, MD PhD, Jeffrey M Venstrom
Journal: Blood
Blood (2016) 128 (22): 913.
https://doi.org/10.1182/blood.V128.22.913.913
Published: 2016